Aker BioMarine ASA - Invitation to presentation of the fourth quarter 2025 results

About this update from Aker Biomarine Asa

Aker BioMarine will release the fourth quarter 2025 results on Thursday 12February 2026 at 07:00 CET.At 09:00 CET on the same day, the management will host a webcast to presenttheresults. Following a presentation, there will be a Q&A session where writtenquestions can be submitted to [email protected] webcasted presentation will be in English. To join, please use the linkthatwill be available at www.akerbiomarine.com/investor.A replay of the presentation and Q&A session will be made available soon afterthe presentation at the same web page.For further information, please contact Christopher Robin Vinter, VP Strategic Finance & IRMobile: +47 911 60 820Email: [email protected] Aker BioMarineAker BioMarine is a leading human health and nutrition innovator that developskrill-derived products for consumer health and nutrition. Krill is a natural,powerful, and health-promoting source of nutrients from the pristine waters ofAntarctica, and Aker BioMarine has a unique position in its industry. Theingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, andPL+,as well as the consumer brand, Kori Krill. The innovative approach alsoextendsinto the spin-offs AION (reduce and recycle plastic waste across industries)andUnderstory (a protein brand). Aker BioMarine is listed on the Oslo StockExchange (AKBM). More information is available at www.akerbiomarine.com.https://newsweb.oslobors.no/message/665455

View stock analysis, news, and events for Aker Biomarine Asa